Iluminada Corripio
Datos Biográficos
| ID | 6778100 |
|---|---|
| NOMBRE | Iluminada Corripio |
| NOMBRES | Iluminada |
| APELLIDO | Corripio |
| FIRMA | CORRIPIO I |
| AFILIACIONES | Hospital de Sant Pau |
| ORCID | 0000-0003-2562-711X |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 5 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 5 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2016 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2023 |
| ÍNDICE H | 0 |
Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls
BACKGROUND: Traumatic life events (TLEs) are one of the most robust environmental risk factors for the onset of first-episode psychosis (FEP). AIMS: To explore TLEs in FEP patients and healthy controls (HC), to analyze gender differences and to examine whether TLEs were associated with sociodemographic, clinical and psychofunctional variables in all FEP sample and split by age. METHODS: Descriptive and cross-sectional study. Three hundred and thi…
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia
Although the availability of services was different in each region, most of the services provided were sufficiently similar to allow the implementation of the same ICT solution in the three places
Results of the m-Resist feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia
The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)
M-Resist, a modular intervention programme addressed to patients with treatment-resistant schizoprenia
In European Union, between 0.2 and 2.6% of the population suffer from psychotic disorders (Wittchen et al., 2011). The largest group is patients with schizophrenia, and around 40% can be considered resistant to pharmacological treatment (Essock et al., 1996; Kennedy et al., 2014). Standard intervention in patients with treatment-resistant schizophrenia (TRS) is difficult due to the persistence of positive symptoms, extensive periods of hospitaliz…
An innovative and integrative m-Health solution for treatment resistant schizophrenia patients
In the European Union, it is estimated that around 5 million people (0.2-2.6%) suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant (Juarez-Reyes et al., 1995; Essock et al., 1996). The standard intervention in patients with resistant schizophrenia is complex, mainly for the presence of persistent positive symptomatology, extensive periods of hospital care and greater risk of multi-m…
Sin obras prominentes en esta página.
An innovative and integrative m-Health solution for treatment resistant schizophrenia patients
In the European Union, it is estimated that around 5 million people (0.2-2.6%) suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant (Juarez-Reyes et al., 1995; Essock et al., 1996). The standard intervention in patients with resistant schizophrenia is complex, mainly for the presence of persistent positive symptomatology, extensive periods of hospital care and greater risk of multi-m…
M-Resist, a modular intervention programme addressed to patients with treatment-resistant schizoprenia
In European Union, between 0.2 and 2.6% of the population suffer from psychotic disorders (Wittchen et al., 2011). The largest group is patients with schizophrenia, and around 40% can be considered resistant to pharmacological treatment (Essock et al., 1996; Kennedy et al., 2014). Standard intervention in patients with treatment-resistant schizophrenia (TRS) is difficult due to the persistence of positive symptoms, extensive periods of hospitaliz…
Results of the m-Resist feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia
The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia
Although the availability of services was different in each region, most of the services provided were sufficiently similar to allow the implementation of the same ICT solution in the three places
Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls
BACKGROUND: Traumatic life events (TLEs) are one of the most robust environmental risk factors for the onset of first-episode psychosis (FEP). AIMS: To explore TLEs in FEP patients and healthy controls (HC), to analyze gender differences and to examine whether TLEs were associated with sociodemographic, clinical and psychofunctional variables in all FEP sample and split by age. METHODS: Descriptive and cross-sectional study. Three hundred and thi…
Medicine (5 obras) · Psychiatry (5 obras) · Schizophrenia (object-oriented programming (4 obras) · Digital Mental Health Interventions (3 obras) · Schizophrenia research and treatment (3 obras) · Family Caregiving in Mental Illness (2 obras) · Intervention (counseling (2 obras) · Mobile Health and mHealth Applications (2 obras) · Psychology (2 obras) · Psychosocial (2 obras)